[Expression of survivin mRNA in HHT-induced cell apoptosis of hematological malignancy cell lines]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Mar;35(2):204-8. doi: 10.3785/j.issn.1008-9292.2006.02.017.
[Article in Chinese]

Abstract

Objective: To investigate the expression of survivin mRNA in hematological malignancy cells and its correlation with HHT-induced cell apoptosis.

Methods: Hematological malignancy cell lines MUTZ-1, K562, Jurkat, RPMI and HL60 were treated with HHT in vitro. Cell apoptosis was observed by flow cytometry (FCM) and the expression of surviving and XIAP mRNA was evaluated with semi-quantitative RT-PCR.

Result: The expression of survivin mRNA on cell lines was negatively correlated to HHT-induced cell apoptotic rate (r=-0.980, P=0.003). There were no significant differences in XIAP expression among these 5 cell lines.

Conclusion: Survivin could be used as a new marker for drug-sensitivity and a new target for treatment of hematological malignancies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • HL-60 Cells
  • Harringtonines / pharmacology*
  • Humans
  • Inhibitor of Apoptosis Proteins
  • K562 Cells
  • Microtubule-Associated Proteins / biosynthesis*
  • Microtubule-Associated Proteins / genetics
  • Myelodysplastic Syndromes / metabolism
  • Myelodysplastic Syndromes / pathology*
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Survivin
  • Tumor Cells, Cultured

Substances

  • BIRC5 protein, human
  • Harringtonines
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • RNA, Messenger
  • Survivin
  • harringtonin